Evaluation of Long-Term Implanted Sensor in Patients on Quality of Life
NCT04161651 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2019-11-20
Summary
Evaluation of Long-Term Implanted Sensor in Patients on Quality of life
Conditions
Interventions
- DEVICE
-
eversense
eversense CGM
Sponsors & Collaborators
-
DYN Diagnostic LTD
collaborator UNKNOWN -
Meir Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-30
- Primary Completion
- 2020-10-31
- Completion
- 2020-10-31
More Related Trials
-
A Performance Evaluation of the Harmony 1 Sensors in Adults and Pediatrics
NCT02456922 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Effects of Intermitent Continuous Glucose Monitoring in Type 1 Diabetes
NCT05095610 ·Status: COMPLETED
-
Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
NCT02465411 ·Status: COMPLETED ·Phase: NA
-
One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™
NCT02939118 ·Status: COMPLETED
-
Smartguard Use in Real Life : a Longitudinal Study in Patients With Type 1 Diabetes
NCT03047486 ·Status: COMPLETED
-
Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes
NCT02854696 ·Status: UNKNOWN ·Phase: PHASE3
-
Feasibility Study of an Integrated Sensor and Infusion Set
NCT01770561 ·Status: COMPLETED ·Phase: NA
-
Use of Real-time Continuous Glucose Monitoring System in Patients With Type 1 Diabetes Mellitus
NCT00824148 ·Status: COMPLETED ·Phase: NA
-
New Glucose Sensor Pediatric
NCT01161043 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes
NCT07325461 ·Status: RECRUITING ·Phase: NA
-
IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo
NCT04190693 ·Status: COMPLETED ·Phase: PHASE1
-
The Multi-Sensor Distance Accuracy Study
NCT02241993 ·Status: COMPLETED
-
A Performance Evaluation of the Enlite 3 Sensor
NCT02649010 ·Status: WITHDRAWN ·Phase: NA
-
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
NCT07126873 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics
NCT00499954 ·Status: COMPLETED
-
Effectiveness Study of the Guardian RT in Type 1 Diabetics
NCT01331343 ·Status: COMPLETED ·Phase: PHASE4
-
Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use
NCT05204134 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.
NCT02103595 ·Status: COMPLETED ·Phase: NA
-
Glucose Counterregulation in Long Standing Type 1 Diabetes
NCT01474889 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) Therapy
NCT01104142 ·Status: COMPLETED
-
Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection
NCT07051564 ·Status: RECRUITING ·Phase: NA
-
InPen User Experience
NCT05029271 ·Status: COMPLETED ·Phase: NA
-
Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue for the Treatment of Type-1 Diabetic Patients
NCT00812591 ·Status: COMPLETED ·Phase: NA
-
A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use
NCT01464346 ·Status: COMPLETED ·Phase: NA
-
The International Diabetes Closed Loop (iDCL) Trial: Protocol 1
NCT02985866 ·Status: COMPLETED ·Phase: NA